Axsome Therapeutics (NASDAQ:AXSM) Given “Buy” Rating at HC Wainwright
HC Wainwright reaffirmed their buy rating on shares of Axsome Therapeutics (NASDAQ:AXSM – Free Report) in a research note published on Thursday,Benzinga reports. They currently have a $200.00 price target on the stock. A number of other equities research analysts have also recently issued reports on AXSM. Truist Financial upped their price objective on shares […]
HC Wainwright reaffirmed their buy rating on shares of Axsome Therapeutics (NASDAQ:AXSM – Free Report) in a research note published on Thursday,Benzinga reports. They currently have a $200.00 price target on the stock. A number of other equities research analysts have also recently issued reports on AXSM. Truist Financial upped their price objective on shares […]
